Know Cancer

or
forgot password

Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity in Thoracic Malignancies


N/A
18 Years
N/A
Not Enrolling
Both
Lung Neoplasms

Thank you

Trial Information

Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity in Thoracic Malignancies


Inclusion Criteria:



Patients receiving radiation therapy for lung cancer combined with surgery either pre or
post RT to the chest for lung cancer not associated with atelectasis, pleural effusion.

Patients receiving HDR Brachytherapy for lung cancer.

Patients receiving concomitant radiation and interferon therapy for lung cancer.

Patients receiving concomitant chemotherapy and radiation for lung cancer. Prior drug
therapy does not make patients ineligible.

Karnofsky ≥ 70 %.

There are no age restrictions.

Acceptable bone marrow function - WBC 2 3000/mm3, platelet count > 100,000, hematocrit ≥
33%, hemoglobin ≥ 11 gms/dl.

Life expectancy > 6 months.

Patients must sign informed consent meeting all federal and institutional guidelines.

Exclusion Criteria:

Patients not meeting eligibility criteria stated above

Type of Study:

Observational

Study Design:

Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Yuhchyau Chen, MD, Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universtiy of Rochester, Dept of Radiation Oncology

Authority:

United States: Institutional Review Board

Study ID:

URCC 4595

NCT ID:

NCT00178230

Start Date:

Completion Date:

Related Keywords:

  • Lung Neoplasms
  • Neoplasms
  • Lung Neoplasms

Name

Location

University of Rochester, Dept. Radiation OncologyRochester, New York  14642